
SillaJen, Inc. — Investor Relations & Filings
SillaJen, Inc. is a biotechnology company focused on the research and development of oncolytic immunotherapeutics for cancer treatment. The company engineers genetically modified viruses designed to selectively target and destroy cancer cells while stimulating a systemic anti-tumor immune response. Its lead product candidate is Pexa-Vec (JX-594), an oncolytic vaccinia virus developed for the treatment of various solid tumors. SillaJen's core activity involves advancing its pipeline of novel cancer-fighting viral therapies through clinical development.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 분기보고서 (2026.03) | 2026-05-15 | Korean | |
| 정기주주총회결과 | 2026-03-27 | Korean | |
| 대표이사변경 | 2026-03-27 | Korean | |
| 감사보고서제출 | 2026-03-19 | Korean | |
| 사업보고서 (2025.12) | 2026-03-19 | Korean | |
| 의결권대리행사권유참고서류 | 2026-03-05 | Korean |
Browse filings by year
9 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
12 filings
| |||||
| 46357249 | 분기보고서 (2026.03) | 2026-05-15 | Korean | ||
| 33056252 | 정기주주총회결과 | 2026-03-27 | Korean | ||
| 33056250 | 대표이사변경 | 2026-03-27 | Korean | ||
| 32985408 | 감사보고서제출 | 2026-03-19 | Korean | ||
| 32985321 | 사업보고서 (2025.12) | 2026-03-19 | Korean | ||
| 32896951 | 의결권대리행사권유참고서류 | 2026-03-05 | Korean | ||
| 32879728 | 주주총회소집공고 | 2026-03-04 | Korean | ||
| 32879679 | 주주총회소집결의 | 2026-03-04 | Korean | ||
| 32879678 | 주주총회집중일개최사유신고 | 2026-03-04 | Korean | ||
| 32876095 | [기재정정]주식매수선택권부여에관한신고 | 2026-03-04 | Korean | ||
| 32875472 | 주식매수선택권부여에관한신고 | 2026-03-04 | Korean | ||
| 14485704 | 매출액또는손익구조30%(대규모법인은15%)이상변동 | 2026-02-05 | Korean | ||
|
2025
3 filings
| |||||
| 33025266 | 기업설명회(IR)개최 | 2025-10-20 | Korean | ||
| 33023071 | 투자판단관련주요경영사항(임상시험계획변경승인) (진행성 고형암 또는 재발성/불응성 급성 골수성 백혈병 환자를 대상으로 BAL0891의 단일요법 및 항암화학요법 또는 티스렐리주맙과의 병용요법에 대한 미국 FDA 제1상 임상시험 계획(IND) 변경 승인) | 2025-10-10 | Korean | ||
| 33019313 | [기재정정]투자판단관련주요경영사항(임상시험계획변경승인) (진행성 고형암 또는 재발성/불응성 급성 골수성 백혈병 환자를 대상으로 BAL0891의 단일요법 및 항암화학요법 또는 티스렐리주맙과의 병용요법에 대한 식품의약품안전처 제1상 임상시험 계획 변경 승인) | 2025-09-23 | Korean | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Aptose Biosciences Inc.
Clinical-stage company developing targeted precision medici…
|
APS | CA | Professional, scientific and te… |
|
APURES CO., LTD.
Biotech firm providing MICROPIG models, bio-resources, and …
|
149300 | KR | Professional, scientific and te… |
|
Aran Research & Development (1982) Ltd.
A product design and development firm providing services fr…
|
ARAN | IL | Professional, scientific and te… |
|
Arch Biopartners Inc.
Developing novel drugs for acute kidney injury (AKI) and ch…
|
ARCH | CA | Professional, scientific and te… |
|
ARCHER MATERIALS LIMITED
Develops semiconductor devices for quantum computing and me…
|
AXE | AU | Professional, scientific and te… |
|
ARGENICA THERAPEUTICS LIMITED
Clinical-stage developer of neuroprotective drugs for acute…
|
AGN | AU | Professional, scientific and te… |
|
ARIUS Research Inc.
Discovery and development of targeted antibody therapeutics…
|
ARI | CA | Professional, scientific and te… |
|
AROVELLA THERAPEUTICS LIMITED
Develops off-the-shelf iNKT cell therapies for blood cancer…
|
ALA | AU | Professional, scientific and te… |
|
Artiva Biotherapeutics, Inc.
Develops allogeneic, off-the-shelf NK cell therapies for ca…
|
ARTV | US | Professional, scientific and te… |
|
ARVINAS, INC.
Clinical-stage biopharma developing therapeutics based on t…
|
ARVN | US | Professional, scientific and te… |
SillaJen, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/16710/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=16710 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=16710 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=16710 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 16710}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for SillaJen, Inc. (id: 16710)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.